www.fdanews.com/articles/157474-fda-grants-priority-review-to-mallinckrodt-s-mnk-795

FDA Grants Priority Review to Mallinckrodt’s MNK-795

July 31, 2013

The FDA has accepted for priority review Mallinckrodt’s NDA for MNK-795, a controlled-release combination of oxycodone and acetaminophen.
PharmTech